CERRITOS, Calif., Dec. 12, 2018 /PRNewswire/ — Certain oral bacteria are associated with multiple diseases, including periodontitis in the oral cavity, and potentially Alzheimer’s disease, diabetes, stroke, cardiovascular disease, and some forms of oral and non-oral cancer. New research shows that the minimally-invasive LANAP® protocol with the PerioLase MVP-7 laser can eliminate or markedly reduce these dangerous microbial pathogens around teeth. As published in the Journal of the International Academy of Periodontology, the LANAP® protocol is able to immediately decrease bacteria associated with severe human periodontitis to levels undetectable by microbial culture, even in periodontal pockets greater than 6 millimeters.
The peer-reviewed research study, “Immediate Effects of Laser-Assisted New Attachment Procedure (LANAP) on Human Periodontitis Microbiota,” was authored by periodontists Thomas K. McCawley, DDS; Mark N. McCawley, DMD, MS; and Thomas E. Rams, DDS, MHS, PhD.
In the study, 20 systemically healthy adults with severe periodontitis were treated with the LANAP® protocol while 6 others received conventional ultrasonic root debridement alone. Subgingival biofilm specimens were collected before and immediately following the completion of treatments and analyzed using anaerobic microbial culture techniques. The results found that 85% of patients treated with the LANAP® protocol were completely culture-negative immediately after treatment for red and orange complex bacterial species, which are strongly associated with severe periodontitis, in comparison to only 16.7% of patients treated with conventional ultrasonic root debridement.
“The LANAP® protocol provided a superior immediate post-treatment microbiological outcome, which is very important in the regeneration of damaged periodontal tissues back to health,” notes lead study author Dr. Thomas McCawley.
“Drs. McCawley and Dr. Rams have independently confirmed the effectiveness of the LANAP® protocol in significantly reducing the bacteria associated with severe periodontitis,” states Robert H. Gregg II, DDS, founder of Millennium Dental Technologies and inventor of the LANAP® protocol. “This data on the antimicrobial effects of LANAP® surgery with the free-running pulsed PerioLase MVP-7 Nd:YAG laser adds to the body of research supporting the inclusion of LANAP® treatment as part of the standard of care for periodontal disease treatment.”
Favorable changes in periodontal pocket microbial community structure induced by the LANAP® protocol, as demonstrated in this new research study, adds insight into predictably beneficial LANAP® protocol treatment outcomes documented by two human histological studies, more than 420 published human clinical patient cases, and a research-based clearance in 2016 for True Periodontal Regeneration™ by the United States Food and Drug Administration (FDA).
Dr. Thomas McCawley, a pioneer in periodontal laser therapy, and Dr. Mark McCawley, board certified in periodontology and dental implant surgery, practice at the McCawley Center for Laser Periodontics and Implants in Fort Lauderdale, FL. Dr. Rams is a Professor in the dental school Department of Periodontology and Oral Implantology, and the medical school Department of Microbiology and Immunology at Temple University, Philadelphia, PA.
ABOUT MILLENNIUM DENTAL TECHNOLOGIES, INC.: Millennium Dental Technologies, Inc., is the developer of the LANAP protocol for the treatment of gum disease, the LAPIP protocol for ailing dental implants, and the manufacturer of the PerioLase MVP-7 dental laser. By providing a simple and comfortable experience with unique bone-building clinical results, MDT’s FDA-cleared LANAP protocol removes the fear from gum disease treatment, offering a vastly less painful and less invasive regenerative treatment alternative to conventional surgery. The company’s founding clinician, Robert H. Gregg II, continues to operate the company with the vision: To create better clinical outcomes in periodontal disease patients—remaining true to the guiding principle—”It’s all about the patient.”
